Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > JP. D. HER2 MAb-Topoisomerase I>
JP. D. HER2 MAb-Topoisomerase I>'s subsections
(*) USA OK Date: 2019. 12.20. (1)
(*) USA OK Date: 2022. 05.05. (2)
(*) USA OK Date: 2022. 08.06. (3)
(1) Received >2 anti-HER2-based reg
(2) Received >1 anti-HER2-based reg
(3) HER2-low (IHC 1+ or IHC 2+/ISH-
>nhibitor Conjugate
Companies
HER2 MAb: TrastuzuMAb
HER2: Human Epidermal growth factor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2022. 07.05.
RTM
RTM Web-Site
TopoIsomerase I Inh.: Deruxtecan
JP. D. HER2 MAb-Topoisomerase I>'s products
This section has no products